Simvastatin induces heme oxygenase-1 via NF-E2-related factor 2 (Nrf2) activation through ERK and PI3K/Akt pathway in colon cancer-Reference-Cited by-同舟云学术

Simvastatin induces heme oxygenase-1 via NF-E2-related factor 2 (Nrf2) activation through ERK and PI3K/Akt pathway in colon cancer

Published:2016-06-15 Issue:29 Volume:7 Page:46219-46229
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Jang Hyun Joo¹,Hong Eun Mi¹,Kim Mikang¹,Kim Jae Hyun¹,Jang Juah¹,Park Se Woo¹,Byun Hyun Wu²,Koh Dong Hee¹,Choi Min Ho¹,Kae Sea Hyub¹,Lee Jin¹

Affiliation:

1. Division of Gastroenterology, Department of Internal Medicine, Dongtan Sacred Heart Hospital, Hallym University School of Medicine, Gyeonggi do, Korea

2. Division of Gastroenterology, Department of Internal Medicine, Hangang Sacred Heart Hospital, Hallym University School of Medicine, Seoul, Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism of Action and Therapeutic Implications of Nrf2/HO-1 in Inflammatory Bowel Disease;Antioxidants;2024-08-20

2. Regulatory effects of statins on Akt signaling for prevention of cancers;Cellular Signalling;2024-08

3. Pharmacotherapeutic Considerations on Telomere Biology: The Positive Effect of Pharmacologically Active Substances on Telomere Length;International Journal of Molecular Sciences;2024-07-13

4. Expression of human dCTP pyrophosphatase 1 (DCTPP1) and its association with cisplatin resistance characteristics in ovarian cancer;Journal of Cellular and Molecular Medicine;2024-04-30

5. Simvastatin-Mediated Nrf2 Activation Induces Fetal Hemoglobin and Antioxidant Enzyme Expression to Ameliorate the Phenotype of Sickle Cell Disease;Antioxidants;2024-03-11